Governance, Sustainability And Development

CASE STUDIES

Aboubakar YARI1 & Venus YARI1

-----------------

Affiliation:

Governance, Sustainability And Development

CASE STUDIES

Aboubakar YARI1 & Venus YARI1

-----------------

Affiliation:

Abstract:

The new global development concepts, the United Nations Millennium Project and the United States Millennium Challenge Account, adopted at the turn of the new millennium in 2000, both emphasize good governance, sustainability, and an increased role for the private sector in development programs of developing countries. The Biotech tropicana Systems are a private Biotech company that specialized in biotechnology innovations adapted to the needs of developing countries.. From daily experiences of the Biotech tropicana Systems working in developing countries, here we select and discuss two poorly governed and unsustainable development programs in the public sector that further reinforce our choice to operate through the private and strictly adhere to the new way development concepts adopted at the dawn of the new millennium.

Keywords: Good governance: Poor Governance; Sustainability; Development: Capacity Building: Technology Transfer

Background:

The United Nations Millennium Project was initiated in 2002 to propose strategies to achieve the Millennium Development Goals adopted in 2000 by head of States and governments., Unlike the political Millennium Development Goals coordinated by head of States and governments, the Millennium Project is coordinated by a panel of scientist and development experts. [1:2]  The Biotech tropicana Systems operate within the framework of the Millennium Project coordinated by a panel of scientists, not the Millennium Development Goals.

The United States Millennium Challenge Account is a global development program proposed by the Bush Administration in 20002. By early 2003, an Act of the United States congress transformed the Bush Administration MCA into the United States global development Millennium Challenge Corporation, MCC. The MCC is operated by a panel of scientists and development experts. The Biotech tropicana Systems operate within the framework of the US MCC, not the MCA. [3]

Both the United Nations millennium project and the United States millennium challenge corporation emphasize good governance, sustainability, and an increased role of the private sector in development processes in developing countries.

Founded in 2000, the Biotech tropicana Systems are a private biotech company that specialized in innovation, development, and commercialization of biotechnologies adapted to the needs of developing countries. [4]

Here, we discuss two cases of poor governance in a program of capacity building and a program of technology transfer in developing countries that further reinforce the choice of the Biotech tropicana Systems to strictly adhere to the new way global development concepts adopted at the turn of the new millennium, the UN millennium project and the US MCC.

Discussion:

Case # 1: A Capacity Building Program

The Biotech tropicana Systems collaborate in a capacity building project in a developing country aiming to create HIV genome processing capability. The project was designed in two phases. Phase 1 aims to create capacity to systematically monitor resistant strains of the virus at population level. The result of phase 1 can then be used in phase 2 to purchase and distribute anti HIV drugs. Here, it is important to specify that the project was owned by foreign partner not the Biotech tropicana Systems. Scientific expert panels recommended phase 1 before phase 2, to avoid purchasing drugs against which there is a high frequency of resistance within that population and to maximize benefits for the patients. In this project, the developing world partner demonstrated poor governance. Project owner moved to phase 2 without implementing phase 1 in violation of scientific expert set guidelines. The result is a blind processing without any data on distribution of resistance strains of the virus within that population and lost of opportunity to build capacity in HIV genome processing. HIV is an RNA virus. A couple of year later, ebola another RNA virus hits. Developing country once more waited aid to address the ebola crisis. Building RNA virus genome processing capability in phase 1 of the HIV project would create capacity to quickly address the ebola crisis with few additional modifications. The far away aid donor will need a reasonable time to process request, mobilize personal and resources before responding to a request out of their schedule: a reasonable delay response. Building capacity in phase 1 of project would create conditions for a quick response while awaiting delayed additional delay assistance and would save numerous valuable lost lives.

Using internal private fund the Biotech tropicana Systems initiated the innovation of an ebola tracking system that was further expanded to real time pathogen tracking system. Our tracking systems are designed not only to quickly diagnose the pathogen but also to track its spread in real time to quickly advise authorities to remove vulnerable populations from the path of spread of a deadly pathogen such as ebola and save valuable lives.  

Case # 2: A Technology transfer Program

Studying abroad on stipend to acquire and transfer technological capacity, we share classes with other foreign students studying out of stipend. The out of stipend students must pay $ 10.000 USD in tuition and fees per year and another $ 10.000 USD in miscellaneous and living expenses. the on stipend students have the tuition and fees waived and receive additional fund for miscellaneous and living expenses. From the cost for out of stipend students, one may estimate the cost of training a specialist in a field between $ 100.000 USD and $ 150.000 USD for the host country. On return to country of origin many trained specialists ended up in offices performing administrative work out of their field training:  a clear cut demonstration of poor governance. In the biotech tropicana Systems, operating through the private sector we could add value on any dollar spent in a training program by performing in our field of training and not sitting in an office.

Key Facts:

1. Between 2000 and 2015, the Biotech troppicana Systems receive zero grants of other alternative form of funding. The systems operate exclusively with its internal fund and intellect acquired through its business activities. Yet, strictly adhering to good governance principles and smart application of knowledge, the Biotech tropicana systems registered substantial positive development gains with numerous innovations and inventions.
2. Competing groups, particularly from the public sector receive large amount of grants in cash, computers, vehicles and other utilities essential for a development program. Our investigations showed that many of these competing groups registered negative development gains. We trace many thieves  of our work equipment’s back to these competing groups in failed attempts to steal our hard work acquired positive results.

Analysis:

In 2007 the African Union initiated a biotechnology for development program coordinated by a panel of scientists operating both from within and from the diaspora. The panel of scientists, The High Level African Panel on Modern Biotechnology coordinate its activities with the African Union Commission in Addis Ababa, Ethiopia, through a team of development experts, under NEPAD, the New Partnership for Africa’s Development in Pretoria, South Africa. [5] The Biotech tropicana Systems coordinated its business activities in territories of the African Union, within the framework of the panel of scientists.  

Operating in the scientific frameworks of the United Nations Millennium project, the United States Millennium Challenge Corporation and the High level African Panel on modern Biotechnology, the Biotech tropicana Systems succeeded in operating its incubators in developing countries. Not without challenges. Yet strictly adhering good governance principles and smart application of knowledge we successfully submitted and get approval of our work before scientific committees on all continents on planet earth with our SMARThivPACK in Asia, the Mobile Life Box in Europe, and the SMARThivDRmos in Texas, USA on American continent. Our Genetics programs undr Biotech tropicana,  IncEDUCATIONAL  advance many programs in parner intittions in Africa through our technical assistance program coordinated by Sabic Consulting, Inc. In 15 years from 2000 to 2015 we acquire enough scientific recognition to impose our SMARTtechs concept on a global scale. The Biotech tropicana systems are definitively set as a major player on Biotechnology for the developing world global market. By 2015, we harness enough authority to easily smash down challenges that cause us serious trouble in the early 2000s. the Biotech tropicana systems are out on the global biotech market to stay now and forever.    

Conclusion:

We conclude that poor governance is more harmful to development than lack of resources. Learning from experience, we revise our internal protocols to reinforce principles of good governance, sustainability, and operation through the private sector.

---------------

Biotech tropicana Systems

A place for everyone with a good moral character in a globalizing world.

Biotech tropicana Systems

Simply umbeatable.

Owned and operated by Aboubakar YARI & Venus YARI

-----------------------

References:

[1] United Nations Millennium Project at http://www.millennium-project.org/millennium/overview.html

[2] United Nations Millennium Development goals now Sustainable Development Goals at http://www.un.org/sustainabledevelopment/sustainable-development-goals/

[3] United States Millennium Challenge Corporation at https://www.mcc.gov/about

[4] Biotech tropicana Systems at http://bitechtropicana.ucoz.com/

[5] The High Level African Panel On Modern Biotechnology athttp://www.sarpn.org/documents/d0002770/Freedom_innovate_AU-NEPAD_Aug2007.pdf